MicroRNA 320c-2 (MIR320C2)

MicroRNA 320c-2 (MIR320C2, also known as hsa-mir-320c-2) is a member of the microRNA-320 family, a class of endogenous, non-coding, short (~20–24 nucleotides) RNAs that function in post-transcriptional regulation of gene expression. These microRNAs are produced by sequential processing of longer precursors and are incorporated into the RNA-induced silencing complex (RISC), where they pair imperfectly with target mRNAs, leading to reduced translation or destabilization. MIR320C2 has been implicated in the downregulation of key cell cycle and signaling regulators (e.g., CDK6 in bladder cancer, CREB5 in osteoarthritis, RUNX2 in adipogenesis), resulting in effects such as suppression of cell proliferation, cell cycle arrest, modulation of cell migration and invasion, and promotion of adipocytic differentiation. Dysregulation of MIR320C2 has been reported in cancers (e.g., its downregulation in bladder cancer) and musculoskeletal diseases such as osteoarthritis (notably as a potential plasma biomarker), highlighting its potential utility as a disease biomarker and a future therapeutic target. It is important to note that MIR320C2 is an endogenous microRNA, not a traditional druggable receptor, enzyme, or transporter, so it is generally not a direct therapeutic target. Current research focuses on its utility as a biomarker or via gene modulation (e.g., miRNA mimics or inhibitors) in experimental settings. No direct drugs targeting MIR320C2 are clinically approved or well-documented in the literature. Gene targets regulated by miR-320c (and by extension, MIR320C2) include CDK6 (cell cycle), RUNX2 (adipogenesis/osteogenesis), and CREB5 (signaling), among others. Its role as a biomarker in both cancer and osteoarthritis is better established than its use as a drug target.

Other names

microRNA 320c-2hsa-mir-320c-2MIRN320C2

MIR320C2 acts through antisense inhibition, leading to the targeting and downregulation of specific messenger RNAs (e.g., CDK6, CREB5, RUNX2). This mechanism involves translational repression or mRNA destabilization facilitated by the RNA-induced silencing complex (RISC).